Literature DB >> 6256682

The spectrum of peripheral neuropathy in myeloma.

J J Kelly, R A Kyle, J M Miles, P C O'Brien, P J Dyck.   

Abstract

The records of 20 patients with typical or sclerotic (sclerotic or mixed sclerotic and lytic) multiple myeloma and peripheral neuropathy who were seen during a 13-year period were analyzed to determine the natural history of the neuropathy. In the 10 patients with typical multiple myeloma, the clinical pattern was heterogeneous. Chemotherapy for multiple myeloma did not affect the neuropathy. The 10 patients who had sclerotic myeloma presented in a relatively homogeneous manner, with a predominantly motor neuropathy. Tumoricidal radiation therapy to localized plasmacytomas resulted in pronounced improvement in the neuropathy of two patients, mild improvement in three, and mild improvement in the endocrine abnormalities of one patient.

Entities:  

Mesh:

Year:  1981        PMID: 6256682     DOI: 10.1212/wnl.31.1.24

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

1.  Light chain deposition disease neuropathy resembling amyloid neuropathy in a multiple myeloma patient.

Authors:  M P Grassi; F Clerici; C Perin; M Borella; A Gendarini; A Quattrini; R Nemni; A Mangoni
Journal:  Ital J Neurol Sci       Date:  1998-08

2.  Subclinical peripheral neuropathy in patients with multiple myeloma before chemotherapy is correlated with decreased fingertip innervation density.

Authors:  Alyssa K Kosturakis; Zijing He; Yan Li; Jessica A Boyette-Davis; Nina Shah; Sheeba K Thomas; Haijun Zhang; Elisabeth G Vichaya; Xin Shelley Wang; Gwen Wendelschafer-Crabb; William R Kennedy; Donald A Simone; Charles S Cleeland; Patrick M Dougherty
Journal:  J Clin Oncol       Date:  2014-08-25       Impact factor: 44.544

3.  Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy.

Authors:  Manoj Mittal; Mamatha Pasnoor; Reddiah B Mummaneni; Saud Khan; April McVey; David Saperstein; Laura Herbelin; Larry Ridings; Yunxia Wang; Mazen M Dimachkie; Richard J Barohn
Journal:  Int J Neurosci       Date:  2011-06-15       Impact factor: 2.292

4.  Successful treatment of peripheral neuropathy with chemotherapy in osteosclerotic myeloma.

Authors:  R Parra; J M Fernandez; F Garcia-Bragado; J Bueno; M Biosca
Journal:  J Neurol       Date:  1987-05       Impact factor: 4.849

5.  Macroglobulinemic neuropathy. Experimental macroglobulinemic neuropathy in mice.

Authors:  S M Baird; H C Powell
Journal:  Am J Pathol       Date:  1983-01       Impact factor: 4.307

6.  The mouse blood-brain barrier and blood-nerve barrier for IgG: a tracer study by use of the avidin-biotin system.

Authors:  R J Seitz; K Heininger; G Schwendemann; K V Toyka; W Wechsler
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

7.  Peripheral neuropathy and solitary myeloma: analysis of serum and CSF IgG in two cases.

Authors:  C Milanese; S Procaccia; L La Mantia; E Guzzetti; F Corridori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-05       Impact factor: 10.154

8.  [POEMS syndrome. A rare variant of osteosclerotic multiple myeloma with polyneuropathy, organomegaly, endocrinopathy, M-gradient and skin lesions].

Authors:  M Cohnen; M Uppenkamp; P Meusers; G Brittinger
Journal:  Med Klin (Munich)       Date:  1998-11-15

9.  Adult-onset mixed myopathy with nemaline rods, minicores, and central cores: a muscle disorder mimicking polymyositis.

Authors:  R J Seitz; K V Toyka; W Wechsler
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

10.  Immunotactoid-like endoneurial deposits in a patient with monoclonal gammopathy of undetermined significance and neuropathy.

Authors:  D F Moorhouse; R I Fox; H C Powell
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.